-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UHBjFDUQ3bYM+R9wTA4BJIzvmaFe55t/PTdpyi6Hw2m0W2oWyTfk/XC0nSYLNgom
 1NHDm8rSOw96GjrvpovL0w==

<SEC-DOCUMENT>0001179110-05-016401.txt : 20050815
<SEC-HEADER>0001179110-05-016401.hdr.sgml : 20050815
<ACCEPTANCE-DATETIME>20050815171254
ACCESSION NUMBER:		0001179110-05-016401
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20050812
FILED AS OF DATE:		20050815
DATE AS OF CHANGE:		20050815

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SKARA SUSAN K
		CENTRAL INDEX KEY:			0001241010

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13305
		FILM NUMBER:		051027869

	MAIL ADDRESS:	
		STREET 1:		C/O WATSON PHARMACEUTICALS INC
		STREET 2:		311 BONNIE CIRCLE
		CITY:			CORONA
		STATE:			CA
		ZIP:			92880

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WATSON PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000884629
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				953872914
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		311 BONNIE CIRCLE
		CITY:			CORONA
		STATE:			CA
		ZIP:			92880
		BUSINESS PHONE:		9092701400

	MAIL ADDRESS:	
		STREET 1:		311 BONNIE CIRCLE
		CITY:			CORONA
		STATE:			CA
		ZIP:			92880
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 4 -
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2005-08-12</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000884629</issuerCik>
        <issuerName>WATSON PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>WPI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001241010</rptOwnerCik>
            <rptOwnerName>SKARA SUSAN K</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O WATSON PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>311 BONNIE CIRCLE</rptOwnerStreet2>
            <rptOwnerCity>CORONA</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92880</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Sr. VP, Human Resources</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock (Restricted)</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <transactionDate>
                <value>2005-08-12</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>1667</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1667</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Options to Purchase Common Stock</value>
                <footnoteId id="F2"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>35.11</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2005-08-12</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>5000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2015-08-12</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, par value $0.0033</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>5000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>5000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These restricted shares of common stock, par value $0.0033, were issued pursuant to the provisions of the Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. (including, but not limited to, restrictions on transferability and certain forfeiture provisions concerning unvested restricted shares).  The restricted shares vest (i) fifty percent on the second anniversary of the date of grant, and (ii) fifty percent on the fourth anniversary of the date of grant.</footnote>
        <footnote id="F2">The options are to be incentive stock options to the extent permitted by law, and thereafter to be non-statutory stock options.</footnote>
        <footnote id="F3">These stock options shall become exercisable in four equal annual installments commencing on August 12, 2006</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/SUSAN K. SKARA</signatureName>
        <signatureDate>2005-08-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----